Project

A Phase III, randomised, Open-Label, multicenter study evaluating the efficacy and safety of adjuvant GDC-9545 compared with physician's choice of adjuvant endocrine Monotherapy in patiens with Estrogen Receptor−Positive, HER2-NegativeEarly Breat Cancer

Ongoing - recruitment closed · 2022 until 2030

Huober Jens, Sennhauser Andrina, Quinter Janine